These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1964566)
1. An ultrastructural study of transcutaneous migration of polymorphonuclear leukocytes following application of leukotriene B4. Paulissen M; Peereboom-Stegeman JH; van de Kerkhof PC Skin Pharmacol; 1990; 3(4):236-47. PubMed ID: 1964566 [TBL] [Abstract][Full Text] [Related]
2. An ultrastructural study of the response of normal skin to epicutaneous application of leukotriene B4. van de Kerkhof PC; Peereboom-Stegeman JH; Boeijen J J Dermatol; 1991 May; 18(5):271-6. PubMed ID: 1658100 [TBL] [Abstract][Full Text] [Related]
3. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions. Lammers AM; van de Kerkhof PC Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753 [TBL] [Abstract][Full Text] [Related]
4. The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin. Wozel G; Chang A; Zultak M; Czarnetzki BM; Happle R; Barth J; van de Kerkhof PC Arch Dermatol Res; 1991; 283(3):158-61. PubMed ID: 1651071 [TBL] [Abstract][Full Text] [Related]
5. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin. Lammers AM; van de Kerkhof PC Br J Dermatol; 1987 Apr; 116(4):521-4. PubMed ID: 3034322 [TBL] [Abstract][Full Text] [Related]
6. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis. Lammers AM; van de Kerkhof PC; Mier PD Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194 [TBL] [Abstract][Full Text] [Related]
7. Oxygen free radicals and leukotriene B4 induced increase in vascular leakage is mediated by polymorphonuclear leukocytes. Björk J; Arfors KE Agents Actions Suppl; 1982; 11():63-72. PubMed ID: 6295114 [TBL] [Abstract][Full Text] [Related]
8. Chemotaxis of polymorphonuclear leukocytes towards LTB4 in patients with psoriasis in vitro. Sun RZ; Zhou DY; Zheng MR; Yue TL Chin Med J (Engl); 1990 Jul; 103(7):595-8. PubMed ID: 2170083 [TBL] [Abstract][Full Text] [Related]
9. Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes. Lammers AM; van de Kerkhof PC Br J Dermatol; 1987 Sep; 117(3):297-300. PubMed ID: 2823858 [TBL] [Abstract][Full Text] [Related]
10. Dithranol modulates the leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes. Chang A; Alkemade H; van de Kerkhof PC J Invest Dermatol; 1989 Jun; 92(6):806-8. PubMed ID: 2542415 [TBL] [Abstract][Full Text] [Related]
11. Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions. Seyger MM; van Pelt JP; van den Born J; Latijnhouwers MA; de Jong EM Arch Dermatol Res; 1997 May; 289(6):331-6. PubMed ID: 9209678 [TBL] [Abstract][Full Text] [Related]
12. Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion. Hoover RL; Karnovsky MJ; Austen KF; Corey EJ; Lewis RA Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2191-3. PubMed ID: 6326110 [TBL] [Abstract][Full Text] [Related]
13. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin. Dowd PM; Black AK; Woollard PW; Greaves MW Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751 [TBL] [Abstract][Full Text] [Related]
14. The dynamics of the response of normal skin to single and multiple epicutaneous leukotriene B4 applications analysed by three-colour flow cytometry. Glade CP; Botermans RJ; van Erp PE; van de Kerkhof PC Acta Derm Venereol; 1995 Nov; 75(6):437-41. PubMed ID: 8651019 [TBL] [Abstract][Full Text] [Related]
15. Leukotriene B4 induces lung injury in the rabbit: role of neutrophils and effect of indomethacin. Yoshimura K; Nakagawa S; Koyama S; Kobayashi T; Homma T J Appl Physiol (1985); 1993 May; 74(5):2174-9. PubMed ID: 8393000 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study. Rossi AG; MacIntyre DE; Jones CJ; McMillan RM J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164 [TBL] [Abstract][Full Text] [Related]
17. The metabolism of leukotriene B4 by peripheral blood polymorphonuclear leukocytes in psoriasis. Maurice PD; Camp RD; Allen BR Prostaglandins; 1987 Jun; 33(6):807-18. PubMed ID: 2823314 [TBL] [Abstract][Full Text] [Related]
18. Neutrophil chemotaxis to leukotriene B4 in vitro is decreased for the human neonate. Dos Santos C; Davidson D Pediatr Res; 1993 Mar; 33(3):242-6. PubMed ID: 8384710 [TBL] [Abstract][Full Text] [Related]
19. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111). van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114 [TBL] [Abstract][Full Text] [Related]
20. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products. Cunningham FM; Wong E; Woollard PM; Greaves MW Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]